Today's IPO of Enanta Pharmaceuticals (ENTA) closed +22.7% at $17.18 per share despite initially pricing 4M shares of its common stock at $14, the low-end of the expected $14-$16 range. JPMorgan and Credit Suisse acted as joint book-running managers for the IPO. Leerink Swann and JMP Securities were co-managers.
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs